Literature DB >> 22357843

Interleukin-1 receptor accessory protein organizes neuronal synaptogenesis as a cell adhesion molecule.

Tomoyuki Yoshida1, Tomoko Shiroshima, Sung-Jin Lee, Misato Yasumura, Takeshi Uemura, Xigui Chen, Yoichiro Iwakura, Masayoshi Mishina.   

Abstract

Interleukin-1 receptor accessory protein (IL-1RAcP) is the essential component of receptor complexes mediating immune responses to interleukin-1 family cytokines. IL-1RAcP in the brain exists in two isoforms, IL-1RAcP and IL-1RAcPb, differing only in the C-terminal region. Here, we found robust synaptogenic activities of IL-1RAcP in cultured cortical neurons. Knockdown of IL-1RAcP isoforms in cultured cortical neurons suppressed synapse formation as indicated by decreases of active zone protein Bassoon puncta and dendritic protrusions. IL-1RAcP recovered the accumulation of presynaptic Bassoon puncta, while IL-1RAcPb rescued both Bassoon puncta and dendritic protrusions. Consistently, the expression of IL-1RAcP in cortical neurons enhances the accumulation of Bassoon puncta and that of IL-1RAcPb stimulated both Bassoon puncta accumulation and spinogenesis. IL-1RAcP interacted with protein tyrosine phosphatase (PTP) δ through the extracellular domain. Mini-exon peptides in the Ig-like domains of PTPδ splice variants were critical for their efficient binding to IL-1RAcP. The synaptogenic activities of IL-1RAcP isoforms were diminished in cortical neurons from PTPδ knock-out mice. Correspondingly, PTPδ required IL-1RAcPb to induce postsynaptic differentiation. Thus, IL-1RAcPb bidirectionally regulated synapse formation of cortical neurons. Furthermore, the spine densities of cortical and hippocampal pyramidal neurons were reduced in IL-1RAcP knock-out mice lacking both isoforms. These results suggest that IL-1RAcP isoforms function as trans-synaptic cell adhesion molecules in the brain and organize synapse formation. Thus, IL-1RAcP represents an interesting molecular link between immune systems and synapse formation in the brain.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22357843      PMCID: PMC6621890          DOI: 10.1523/JNEUROSCI.4637-11.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  56 in total

Review 1.  Interleukin 1 in the brain: biology, pathology and therapeutic target.

Authors:  N J Rothwell; G N Luheshi
Journal:  Trends Neurosci       Date:  2000-12       Impact factor: 13.837

Review 2.  Actions of the pro-inflammatory cytokine IL-1 beta on central synaptic transmission.

Authors:  J J O'Connor; A N Coogan
Journal:  Exp Physiol       Date:  1999-07       Impact factor: 2.969

3.  Impaired learning with enhanced hippocampal long-term potentiation in PTPdelta-deficient mice.

Authors:  N Uetani; K Kato; H Ogura; K Mizuno; K Kawano; K Mikoshiba; H Yakura; M Asano; Y Iwakura
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

4.  Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons.

Authors:  P Scheiffele; J Fan; J Choih; R Fetter; T Serafini
Journal:  Cell       Date:  2000-06-09       Impact factor: 41.582

5.  Role of interleukin-1 beta in impairment of contextual fear conditioning caused by social isolation.

Authors:  C R Pugh; K T Nguyen; J L Gonyea; M Fleshner; L R Wakins; S F Maier; J W Rudy
Journal:  Behav Brain Res       Date:  1999-12       Impact factor: 3.332

6.  The inhibitory effect of interleukin-1beta on long-term potentiation is coupled with increased activity of stress-activated protein kinases.

Authors:  E Vereker; E O'Donnell; M A Lynch
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

7.  Identification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. Delineation of a new class of IL-1R-related proteins based on signaling.

Authors:  T L Born; D E Smith; K E Garka; B R Renshaw; J S Bertles; J E Sims
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

8.  A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation.

Authors:  A Carrié; L Jun; T Bienvenu; M C Vinet; N McDonell; P Couvert; R Zemni; A Cardona; G Van Buggenhout; S Frints; B Hamel; C Moraine; H H Ropers; T Strom; G R Howell; A Whittaker; M T Ross; A Kahn; J P Fryns; C Beldjord; P Marynen; J Chelly
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

9.  Cytokines regulate expression of the type 1 interleukin-1 receptor in rat hippocampal neurons and glia.

Authors:  W J Friedman
Journal:  Exp Neurol       Date:  2001-03       Impact factor: 5.330

10.  Subtype switching of vesicular glutamate transporters at parallel fibre-Purkinje cell synapses in developing mouse cerebellum.

Authors:  Taisuke Miyazaki; Masahiro Fukaya; Hidemi Shimizu; Masahiko Watanabe
Journal:  Eur J Neurosci       Date:  2003-06       Impact factor: 3.386

View more
  59 in total

Review 1.  Local sleep.

Authors:  James M Krueger; Joseph T Nguyen; Cheryl J Dykstra-Aiello; Ping Taishi
Journal:  Sleep Med Rev       Date:  2018-11-12       Impact factor: 11.609

Review 2.  Protein tyrosine phosphatases PTPδ, PTPσ, and LAR: presynaptic hubs for synapse organization.

Authors:  Hideto Takahashi; Ann Marie Craig
Journal:  Trends Neurosci       Date:  2013-07-05       Impact factor: 13.837

Review 3.  Alterations in immune cells and mediators in the brain: it's not always neuroinflammation!

Authors:  Myka L Estes; A Kimberley McAllister
Journal:  Brain Pathol       Date:  2014-11       Impact factor: 6.508

4.  The neuron-specific interleukin-1 receptor accessory protein is required for homeostatic sleep and sleep responses to influenza viral challenge in mice.

Authors:  Christopher J Davis; Danielle Dunbrasky; Marcella Oonk; Ping Taishi; Mark R Opp; James M Krueger
Journal:  Brain Behav Immun       Date:  2014-11-04       Impact factor: 7.217

5.  HMGB1 mediates cognitive impairment in sepsis survivors.

Authors:  Sangeeta S Chavan; Patricio T Huerta; Sergio Robbiati; S I Valdes-Ferrer; Mahendar Ochani; Meghan Dancho; Maya Frankfurt; Bruce T Volpe; Kevin J Tracey; Betty Diamond
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

Review 6.  Immune mediators in the brain and peripheral tissues in autism spectrum disorder.

Authors:  Myka L Estes; A Kimberley McAllister
Journal:  Nat Rev Neurosci       Date:  2015-08       Impact factor: 34.870

Review 7.  PTPRD: neurobiology, genetics, and initial pharmacology of a pleiotropic contributor to brain phenotypes.

Authors:  George R Uhl; Maria J Martinez
Journal:  Ann N Y Acad Sci       Date:  2019-01-15       Impact factor: 5.691

8.  Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist.

Authors:  George R Uhl; Maria J Martinez; Paul Paik; Agnieszka Sulima; Guo-Hua Bi; Malliga R Iyer; Eliot Gardner; Kenner C Rice; Zheng-Xiong Xi
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-22       Impact factor: 11.205

Review 9.  Sleep function: Toward elucidating an enigma.

Authors:  James M Krueger; Marcos G Frank; Jonathan P Wisor; Sandip Roy
Journal:  Sleep Med Rev       Date:  2015-08-28       Impact factor: 11.609

10.  GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.

Authors:  Carlos Cruchaga; John S K Kauwe; Oscar Harari; Sheng Chih Jin; Yefei Cai; Celeste M Karch; Bruno A Benitez; Amanda T Jeng; Tara Skorupa; David Carrell; Sarah Bertelsen; Matthew Bailey; David McKean; Joshua M Shulman; Philip L De Jager; Lori Chibnik; David A Bennett; Steve E Arnold; Denise Harold; Rebecca Sims; Amy Gerrish; Julie Williams; Vivianna M Van Deerlin; Virginia M-Y Lee; Leslie M Shaw; John Q Trojanowski; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg; Elaine R Peskind; Douglas Galasko; Anne M Fagan; David M Holtzman; John C Morris; Alison M Goate
Journal:  Neuron       Date:  2013-04-04       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.